These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits. Gezer AO; Kochmanski J; VanOeveren SE; Cole-Strauss A; Kemp CJ; Patterson JR; Miller KM; Kuhn NC; Herman DE; McIntire A; Lipton JW; Luk KC; Fleming SM; Sortwell CE; Bernstein AI Neurobiol Dis; 2020 Jul; 141():104947. PubMed ID: 32422283 [TBL] [Abstract][Full Text] [Related]
3. Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. Centner A; Del Priore I; Chambers N; Cohen SR; Terry ML; Coyle M; Glinski J; Stoll AC; Patterson JR; Kemp CJ; Miller KM; Kubik M; Kuhn N; Luk KC; Sortwell CE; Bishop C Eur J Neurosci; 2024 Apr; 59(7):1585-1603. PubMed ID: 38356120 [TBL] [Abstract][Full Text] [Related]
4. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. Richardson JR; Caudle WM; Wang M; Dean ED; Pennell KD; Miller GW FASEB J; 2006 Aug; 20(10):1695-7. PubMed ID: 16809432 [TBL] [Abstract][Full Text] [Related]
5. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils. Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792 [TBL] [Abstract][Full Text] [Related]
7. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
8. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894 [TBL] [Abstract][Full Text] [Related]
9. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507 [TBL] [Abstract][Full Text] [Related]
10. A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System. Björklund A; Nilsson F; Mattsson B; Hoban DB; Parmar M J Parkinsons Dis; 2022; 12(8):2307-2320. PubMed ID: 36189605 [TBL] [Abstract][Full Text] [Related]
11. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions. Stoll AC; Kemp CJ; Patterson JR; Howe JW; Steece-Collier K; Luk KC; Sortwell CE; Benskey MJ Neurobiol Dis; 2024 Feb; 191():106411. PubMed ID: 38228253 [TBL] [Abstract][Full Text] [Related]
12. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Hatcher JM; Richardson JR; Guillot TS; McCormack AL; Di Monte DA; Jones DP; Pennell KD; Miller GW Exp Neurol; 2007 Apr; 204(2):619-30. PubMed ID: 17291500 [TBL] [Abstract][Full Text] [Related]
13. Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS. Miller KM; Patterson JR; Kochmanski J; Kemp CJ; Stoll AC; Onyekpe CU; Cole-Strauss A; Steece-Collier K; Howe JW; Luk KC; Sortwell CE J Neurosci; 2021 Mar; 41(9):2039-2052. PubMed ID: 33472823 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate. Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728 [TBL] [Abstract][Full Text] [Related]
15. Developmental Dieldrin Exposure Alters DNA Methylation at Genes Related to Dopaminergic Neuron Development and Parkinson's Disease in Mouse Midbrain. Kochmanski J; VanOeveren SE; Patterson JR; Bernstein AI Toxicol Sci; 2019 Jun; 169(2):593-607. PubMed ID: 30859219 [TBL] [Abstract][Full Text] [Related]
16. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
17. Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. Richardson JR; Caudle WM; Wang MZ; Dean ED; Pennell KD; Miller GW Neurotoxicology; 2008 Sep; 29(5):855-63. PubMed ID: 18577399 [TBL] [Abstract][Full Text] [Related]
18. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease. Sossi V; Patterson JR; McCormick S; Kemp CJ; Miller KM; Stoll AC; Kuhn N; Kubik M; Kochmanski J; Luk KC; Sortwell CE Mov Disord; 2022 Aug; 37(8):1739-1748. PubMed ID: 35524682 [TBL] [Abstract][Full Text] [Related]